WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 2'0101 Infant (under 12 months) mortality rate: 482
GDP / capita (US$): 2'5381 Child (under 5 years) mortality rate: 632

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 7'321  7'167  7'013  6'859  6'705  5'379  4'158  3'215 
Births 212  210  209  207  206  188  146  127 
Surviving infants 202  200  199  197  196  177  136  117 
Pop. less than 5 years 987  982  975  963  952  840  635  556 
Pop. less than 15 years 2'783  2'754  2'720  2'679  2'638  2'165  1'756  1'456 
Female 15-49 years 1'824  1'776  1'731  1'688  1'645  1'324  988  712 

Number of reported case

(Click for retrospective incidence data for Papua New Guinea)
Diphtheria 15 
Japanese encephalitis
Measles 12  7'135  4'575  12'125 
Mumps
Pertussis 3'188  6'472  4'625  4'949  2'932  2'280  2'084  2'693 
Polio* 22 
Rubella 33  19  19 
Rubella (CRS)
Tetanus (neonatal) 27  32  56  32  125  138 
Tetanus (total) 27  32  56  32  125  138  115  68 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Papua New Guinea)
Vaccine year result method % card seen                                                
BCG 2004  90     93  88  84  83  80  80  81  92  62 
DTP1 2004  88     93  88  85  83  84  84  84  97 
DTP3 2004  71     93  68  63  61  70  64  59  68  32 
HepB_BD          37  35  31  35  27  24 
HepB3 2004  73     93  68  63  61  89  64  57  20 
Hib3          68  63  61  70  64 
JapEnc         
MCV 2004  78     93  70  67  60  59  58  62  66 
MCV2          53 
PCV1         
PCV3         
Pol3 2004  69     93  69  70  58  70  70  47  68  29 
Rota1         
Rota_last         
Rubella1         
TT2plus          67  59  51  50  35  10  81  50 
PAB         
VAD1          52  18  52 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Papua New Guinea)
BCG 88  84  83  79  79  81  92  62 
DTP1 88  85  83  80  80  84  97  57 
DTP3 68  63  61  56  62  59  68  32 
HepB3 68  63  61  56  62  57  20 
HepB_BD 37  35  31  31  26 
Hib3 68  63  61  56  62 
MCV 70  67  60  55  55  62  67 
MCV2
PAB 65  70  61  61  61  24  78  45 
PCV3
Pol3 69  70  58  61  68  47  68  29 
Rota_last

Number of districts in the country 89  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
70 
   
/
|
|
\
Greater or equal to 90% 26
From 80 to 89% 6
From 50 to 79% 20
Less than 50% 46
Proportion of districts
not reporting DTP3 coverage
2
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 1, 2, 3 months; Yes
HepB birth; Yes
IPV 3 months; Yes From 2015
MR 9, 18 months; Yes From 2015
Measles 6, 9 months; Yes
OPV 1, 2, 3 months; Yes
Pneumo_conj 1, 2, 3 months; Yes
TT 7, 13 years; Yes
VitaminA 6, 12 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 89  89  89  80  89  89  81 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 89  89  89  89  89  89  89 
Nº districts with DTP3 coverage >=80% number 28  35  30  20  30  11  10 
% of districts with DTP3 coverage >=80% From 0 to 100% 31  39  34  22  34  12  11 
Nº districts with measles (MCV1) coverage >=95% number 23  27  19   
% of districts with MCV1 coverage >=95% From 0 to 100% 26  30  21   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  Yes  Yes  Yes  Yes  Yes  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 62  81  45  59  61  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.